angiotensinconvert
membran
protein
activ
site
expos
extracellular
surfac
endotheli
cell
renal
tubular
epithelium
also
epithelia
lung
small
intestin
pois
metabol
circul
peptid
may
includ
angiotensin
ii
potent
vasoconstrictor
product
angiotensin
cleavag
angiotensinconvert
enzym
ace
ec
inde
implic
regul
heart
renal
function
propos
control
concentr
angiotensin
ii
rel
hypotens
metabolit
angiotensin
recent
identifi
function
receptor
coronaviru
caus
sever
acut
respiratori
syndrom
sar
recent
review
see
share
number
characterist
ace
zinccontain
enzym
sensit
anion
activ
howev
unlik
ace
function
carboxypeptidas
suscept
inhibit
classic
ace
inhibitor
elucid
crystal
structur
testicular
ace
tace
model
activ
site
describ
demonstr
structur
determin
underli
differ
enzym
activ
critic
residu
substitut
highlight
gave
rise
elimin
pocket
found
ace
abl
remov
singl
amino
acid
cterminu
substrat
wherea
ace
peptidyl
dipeptidas
shortli
structur
solv
provid
insight
enzym
relat
counterpart
howev
angiotensinconvert
may
play
import
role
cardioren
diseas
also
implic
cellular
receptor
sever
acut
respiratori
syndrom
sar
viru
activesit
model
crystal
structur
solv
recent
highlight
key
differ
counterpart
angiotensinconvert
enzym
ace
respons
differ
substrat
inhibitor
sensit
studi
role
activesit
residu
explor
sitedirect
mutagenesi
found
critic
substrat
bind
replac
caus
enzym
activ
abolish
although
involv
catalysi
act
hydrogen
bond
donor
acceptor
format
tetrahedr
peptid
intermedi
differ
chlorid
sensit
ace
investig
absenc
second
chloridebind
site
confirm
thu
one
chloridebind
site
wherea
ace
two
site
first
studi
address
differ
exist
ace
molecular
level
result
appli
futur
studi
aim
unravel
role
rel
ace
vivo
abbrevi
ace
angiotensinconvert
enzym
mca
acetyl
tace
testicular
ace
feb
journal
feb
j
l
guy
et
al
critic
activesit
residu
feb
journal
feb
becom
increasingli
appar
inde
structur
function
distinct
ace
extracellular
domain
structur
determin
nativ
inhibitorbound
form
zinc
proteas
domain
divid
two
subdomain
defin
movement
subdomain
rel
upon
inhibitor
bind
subdomain
ntermin
contain
zincbind
site
face
deep
cleft
form
two
subdomain
connect
base
cleft
hingebend
motion
observ
upon
inhibitor
bind
occur
subdomain
move
close
gap
bring
critic
residu
group
around
substrat
inhibitor
studi
provid
first
investig
import
key
activesit
residu
sitedirect
mutagenesi
aim
provid
practic
evid
role
substrat
bind
hydrolysi
addit
effect
chlorid
activ
address
basi
differ
sensit
ace
anion
current
understood
bind
cterminu
peptid
substrat
activesit
structur
abl
make
saltbridg
cterminu
inhibitor
henc
propos
involv
bind
cterminu
peptid
substrat
fig
test
hypothesi
use
sitedirect
mutagenesi
replac
arginin
glutamin
residu
ie
counterpart
ace
repres
posit
neutral
chang
side
chain
posit
maintain
hydrophob
surfac
area
compar
purpos
arginin
residu
also
replac
lysin
order
maintain
charg
side
chain
stabl
express
wildtyp
solubl
k
mutant
establish
cell
medium
contain
protein
collect
total
protein
lg
separ
sd
page
express
mutant
enzym
success
protein
migrat
sd
page
appar
r
wildtyp
enzym
fig
top
panel
protein
could
detect
medium
collect
mocktransfect
cell
incub
wildtyp
mutant
protein
lg
total
protein
lm
acetyl
mca
apk
dnp
h
reveal
mutant
although
express
activ
fig
bottom
panel
follow
enzym
activ
observ
k
protein
lg
total
protein
incub
substrat
h
posit
side
chain
therefor
critic
bind
substrat
maintain
posit
charg
posit
suffici
dock
peptid
activ
site
fact
distanc
posit
charg
surfac
bind
pocket
also
crucial
sequenc
align
ace
reveal
ace
residu
shown
involv
stabil
transitionst
intermedi
conserv
inde
locat
rel
zincbind
motif
sequenc
similar
locat
catalyt
histidin
ace
thermolysin
suggest
catalyt
histidin
basi
featur
predict
test
transitionst
stabil
residu
parallel
role
hydrogenbond
cterminu
secondari
amin
group
inhibitor
fig
explor
investig
role
catalysi
histidin
residu
replac
alanin
leucin
l
l
stabl
express
mutant
establish
cell
fig
top
panel
upon
incub
mutant
protein
lg
total
protein
fluorogen
substrat
h
littl
enzym
activ
observ
fig
bottom
panel
subsequ
enzym
activ
examin
extens
hydrolyt
condit
lg
total
protein
incub
mm
mcaapk
dnp
h
result
mutant
enzym
found
consider
less
activ
wildtyp
enzym
tabl
littl
activ
remain
l
less
activ
wildtyp
enzym
subsequ
kinet
analysi
mutant
feasibl
data
establish
import
role
replac
result
enzym
activ
dramat
reduc
model
structur
determin
guy
et
al
towler
et
al
respect
show
correspond
tace
play
key
role
bind
substrat
structur
inform
use
probe
role
residu
catalysi
superposit
activ
site
tace
sever
observ
made
structur
histidin
nitrogen
proton
histidin
side
chain
ne
nitrogen
residu
within
hydrogenbond
distanc
carbonyl
oxygen
amid
group
residu
tace
fig
equival
termin
carboxyl
oxygen
fig
inhibitor
first
histidin
tace
also
within
hydrogenbond
distanc
ace
sp
hybrid
nitrogen
inhibitor
nitrogen
involv
substrat
peptid
bond
cleavag
therefor
like
histidin
act
hydrogen
bond
donor
acceptor
format
tetrahedr
peptid
intermedi
catalysi
fig
contradict
role
describ
towler
et
al
closest
potenti
nitrogen
sp
hybrid
nitrogen
far
away
hydrogenbond
format
instead
may
import
hydrogenbond
oh
suggest
stabil
carbonyl
tetrahedr
intermedi
equival
tyr
drosophila
homologu
anc
pyrococcu
furiosu
carboxypeptidas
zinc
metalloproteas
similar
overal
tertiari
structur
cdomain
ace
equival
residu
suggest
involv
stabil
carbonyl
tetrahedr
intermedi
directli
hydrogen
bond
form
fig
howev
towler
et
al
suggest
far
zincbound
carboxyl
directli
involv
stabil
carbonyl
tetrahedr
intermedi
overal
greater
loss
activ
mutat
decreas
activ
mutat
decreas
would
support
import
role
catalysi
rather
compar
chloridebind
site
tace
chlorid
depend
ace
long
recogn
recent
mutagenesi
studi
shown
fact
arginin
residu
essenti
chlorid
activ
ace
structur
tace
reveal
locat
two
buri
chlorid
ion
second
chlorid
ion
found
bound
water
molecul
two
aminoacid
residu
one
equival
residu
presenc
anoth
chlorid
ion
locat
away
activ
site
unexpect
arginin
residu
found
play
key
role
posit
chlorid
ion
site
sequenc
align
ace
reveal
arginin
residu
chlorid
site
conserv
respect
mutant
therefor
creat
express
cell
fig
top
panel
effect
chlorid
ion
enzym
activ
investig
fig
hydrolysi
mca
apk
dnp
greatli
enhanc
presenc
chlorid
ion
high
concentr
nacl
activ
wildtyp
enzym
increas
fig
mutant
howev
show
expect
loss
chlorid
activ
instead
presenc
high
salt
enzym
activ
greater
mutant
much
sensit
chlorid
ion
wildtyp
enzym
intriguingli
structur
reveal
absenc
bound
chlorid
site
data
combin
suggest
unlik
ace
second
site
exist
therefor
contribut
chlorid
effect
light
find
assumpt
might
actual
site
respons
chlorid
activ
contrast
second
site
bound
chlorid
structur
report
ident
posit
first
bind
site
tace
yet
presenc
nacl
mutant
chloridebind
site
potenti
abolish
respond
approxim
fivefold
increas
activ
fig
slightli
greater
wildtyp
fact
activ
profil
mirror
obtain
wildtyp
enzym
fig
superimpos
structur
tace
inhibitorbound
state
reveal
signific
chang
chlorid
ionbind
site
enzym
design
site
tace
absent
due
substitut
ace
side
chain
project
locat
chlorid
ionbind
site
hydrogen
bond
equival
coordin
chlorid
ion
tace
displac
rel
ace
somewhat
closer
zincbind
site
bind
site
close
proxim
catalyt
site
away
zinc
locat
interfac
subdomain
ii
tabl
residu
ace
equival
hing
region
two
subdomain
henc
bind
chlorid
site
might
expect
affect
zinc
ligand
bind
well
interact
subdomain
ii
effect
would
present
ace
site
absent
interestingli
mutant
site
limit
effect
activ
either
presenc
absenc
chlorid
ion
possibl
result
fact
involv
chlorid
bind
influenc
activ
restrict
effect
substrat
bind
would
appear
fairli
small
howev
sitedirect
mutagenesi
studi
equival
residu
somat
ace
sace
equival
tace
dramat
effect
mutat
caus
increas
activ
angiotensin
substrat
rel
wildtyp
absenc
chlorid
presum
result
chlorid
bind
site
ace
stabil
complex
format
therefor
remov
site
mutat
stabil
complex
format
decreas
chlorid
depend
exert
occup
site
alon
design
subdomain
ii
tabl
residu
coordin
chlorid
ligand
tace
larg
conserv
howev
arg
ly
chang
may
effect
chlorid
affin
ly
nz
interact
less
intim
ace
fig
furthermor
larg
differ
solvat
energi
arg
ly
might
expect
weaken
chlorid
affin
rel
ace
presum
role
site
stabil
nativ
state
subdomain
ii
complex
ligand
although
unlik
direct
influenc
zinc
bind
zinc
ion
separ
tace
coordin
residu
subdomain
may
import
stabil
complex
format
residu
subdomain
ii
involv
directli
substrat
bind
tace
bind
ctermin
carboxi
group
respect
inhibitor
catalysi
equival
tace
similar
hypothesi
propos
role
site
domain
ace
surpris
mutat
littl
effect
activ
either
presenc
absenc
chlorid
may
result
fact
mutant
enzym
still
abl
bind
chlorid
site
retain
activ
effect
residu
within
site
may
import
chlorid
bind
substitut
may
give
rise
dramat
effect
chlorid
activ
exampl
found
coordin
shell
chlorid
ion
close
proxim
catalyt
machineri
therefor
may
affect
stabil
activ
enzym
complex
hydrogenbond
indirectli
replac
may
also
elicit
effect
chlorid
activ
less
obvious
lie
two
residu
upstream
critic
substrat
bind
might
transmit
effect
bind
catalysi
substrat
replac
hydrogenbond
chlorid
ion
may
caus
loss
chloridebind
affin
howev
like
may
caus
underli
chang
chlorid
activ
differ
chlorid
sensit
ace
make
sens
view
fact
one
chloridebind
site
wherea
ace
two
site
one
subdomain
addit
site
found
subdomain
ii
distanc
activ
site
like
differ
affin
chlorid
site
suggest
see
explain
phenomenon
liu
et
al
show
dramat
loss
chlorid
activ
cdomain
ace
site
abolish
howev
effect
noth
enzym
activ
still
observ
case
like
ace
behav
like
singl
occupi
site
contribut
activ
substrat
hydrolysi
chlorid
interestingli
natesh
et
al
suggest
compar
ace
bind
site
anc
may
also
alter
site
may
absent
studi
highlight
import
bind
cterminu
peptid
substrat
complet
loss
activ
observ
result
replac
singl
residu
could
fig
chlorid
bind
yellow
tace
white
bind
site
tace
b
bind
site
tace
residu
number
first
chlorid
ion
green
zinc
ion
grey
spacefil
b
lisinopril
ligand
colour
accord
atom
type
cpk
chlorid
ion
shown
reduc
radiu
demonstr
overlap
clearli
predict
simpli
analysi
activesit
structur
role
catalysi
probe
provid
new
insight
transitionst
stabil
zinc
proteas
eg
ace
mutagenesi
data
therefor
provid
addit
critic
inform
obtain
xray
data
alon
knowledg
gain
mutagenesi
data
valuabl
direct
design
modul
activ
present
studi
carri
develop
inhibitor
despit
emerg
import
enzym
cardiovascular
homoeostasi
viral
entri
mechan
final
comprehens
explan
differ
sensit
ace
chlorid
ion
suggest
relat
physiolog
signific
chlorid
activ
remain
explor
peptid
mcaapk
dnp
synthes
g
knight
univers
cambridg
uk
mutagen
pcr
carri
ml
eppendorf
tube
reaction
volum
typic
reaction
would
contain
mm
dntpmix
reaction
buffer
lm
forward
primer
lm
revers
primer
denatur
templat
dna
lg
u
pfuturbo
dna
polymeras
stratagen
la
jolla
ca
usa
made
steril
deioniz
water
follow
pcr
profil
use
one
cycl
min
cycl
min
min
one
cycl
h
amplif
reaction
treat
dpni
restrict
enzym
uaell
addit
reaction
mixtur
thoroughli
mix
pipet
solut
sever
time
reaction
mixtur
centrifug
microcentrifug
min
incub
h
aliquot
dpnitreat
dna
use
transform
compet
escherichia
coli
cell
plasmid
dna
prepar
singl
coloni
fulli
sequenc
ensur
presenc
desir
point
mutat
absenc
unintend
mutat
transfect
h
cell
grown
confluenc
petri
dish
transient
transfect
monolay
wash
twice
dulbecco
modif
eagl
medium
dmem
transfect
lg
plasmid
dna
pcineo
contain
nucleotid
cdna
encod
truncat
protein
lack
transmembran
cytosol
domain
infram
flag
peptid
per
dish
genejuic
transfect
reagent
use
ratio
dna
reagent
w
v
ad
petri
dish
ml
dmem
incub
h
addit
supplement
dmem
medium
remov
h
start
transfect
monolay
rins
twice
optimem
ml
ad
flask
incub
h
harvest
medium
contain
solubl
secret
protein
media
sampl
contain
protein
concentr
use
centricon
millipor
billerica
usa
kda
cutoff
filter
unit
chlorid
activ
assay
medium
harvest
exchang
mm
hepe
koh
ph
use
centricon
kda
cutoff
filter
unit
obtain
stabl
cell
line
express
solubl
transfect
cell
incub
supplement
medium
h
start
transfect
h
cell
passag
allow
grow
supplement
medium
contain
antibiot
mgaeml
cell
subject
repeat
round
select
reach
confluenc
passag
allow
continu
grow
select
medium
rna
prepar
cell
stabli
express
solubl
perform
use
qiagen
valencia
ca
usa
rneasi
mini
kit
accord
manufactur
guidelin
revers
transcriptas
rt
pcr
carri
use
titanium
onestep
rtpcr
kit
bd
bioscienc
san
jose
ca
usa
accord
manufactur
guidelin
primer
follow
pcr
profil
use
one
cycl
h
cycl
min
cycl
min
min
min
one
cycl
min
amplicon
sequenc
confirm
integr
product
process
carri
mutant
made
studi
protein
concentr
determin
use
bicinchonin
acid
assay
bsa
standard
pngase
f
treatment
new
england
biolab
beverli
usa
perform
accord
manufactur
instruct
protein
separ
sd
page
method
laemmli
sampl
prepar
gel
load
buffer
tri
hcl
ph
w
v
sd
v
v
glycerol
v
v
w
v
bromophenol
blue
heat
min
broadrang
prestain
protein
standard
run
alongsid
sampl
protein
electrophoret
transfer
polyacrylamid
gel
poli
vinyliden
difluorid
membran
use
semidri
blotter
biorad
hercul
ca
usa
membran
incub
overnight
tb
mm
tri
hcl
ph
mm
nacl
contain
w
v
nonfat
dri
milk
tbsm
quick
rins
tb
contain
v
v
tween
tbst
membran
incub
h
room
temperatur
presenc
primari
antibodi
follow
primari
antibodi
dilut
specifi
tbsm
human
polyclon
antibodi
obtain
r
system
europ
ltd
abingdon
oxon
uk
quick
rins
tbst
membran
wash
twice
min
tbst
room
temperatur
membran
incub
h
room
temperatur
appropri
secondari
antibodi
dilut
specifi
tbsm
horseradish
peroxidaseconjug
antigoat
igg
obtain
sigma
tbst
wash
repeat
visual
immunoreact
protein
chemiluminesc
use
ecl
kit
densitometr
analysi
data
captur
use
fuji
imag
system
ccd
camera
aida
softwar
analysi
fluorogen
assay
use
synthet
substrat
mcaapk
dnp
final
concentr
lm
carri
room
temperatur
assay
monitor
continu
measur
increas
fluoresc
excit
nm
emiss
nm
upon
substrat
hydrolysi
use
wallac
victor
fluoresc
plate
reader
turku
finland
initi
veloc
determin
linear
rate
fluoresc
increas
min
time
cours
reaction
product
quantifi
use
standard
solut
mca
